SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-15-000726
Filing Date
2015-03-03
Accepted
2015-03-03 16:05:02
Documents
2
Period of Report
2015-02-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 18152
2 ex17-1.htm EX-17.1 10305
  Complete submission text file 0001493152-15-000726.txt   29784
Mailing Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077
Business Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077 310-474-9809
Targeted Medical Pharma, Inc. (Filer) CIK: 0001420030 (see all company filings)

IRS No.: 205863618 | Fiscal Year End: 1209
Type: 8-K | Act: 34 | File No.: 000-53071 | Film No.: 15669004
SIC: 2834 Pharmaceutical Preparations